ROIV News and Press, Roivant Sciences Ltd. From 11/14/22

Expected cash runway extended into the second half of calendar year 2025 First major PBM/payer contract signed for VTAMA, effective October 1 Over 54,000 VTAMA prescriptions written by approximately 6,400 prescribers since launch show strong demand, with fiscal Q2 2022 n...

The following slide deck was published by Roivant Sciences Ltd. in conjunction with this event. For further details see: Roivant Sciences (ROIV) Investor Presentation - Slideshow

NEW YORK and BASEL, Switzerland, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Affivant, a biotechnology company dedicated to developing novel immune-oncology approaches to activate and enable the innate immune system to fight cancer, will present a poster at the 37 th Annual Meeting of The Society...

Roivant Sciences ( NASDAQ: ROIV ) shares fell 13% Tuesday morning after the biopharmaceutical company priced a primary and secondary public offering of 30M common shares. The offering consists of 20M shares offered by Roivant and 10M shares offered by the selling share...

BASEL, Switzerland and LONDON and NEW YORK and BOSTON, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Roivant Sciences Ltd. (Nasdaq: ROIV), a next-generation biopharmaceutical company dedicated to improving the delivery of healthcare to patients, announced today the pricing of its primary and secondary ...

Roivant Sciences ( NASDAQ: ROIV ) stock fell 7% after hours on Monday after the firm announced a proposed underwritten public offering of $150M of shares. The underwriter will be granted a 30-day option to buy up to $22.5M of additional shares. There can be no assu...

BASEL, Switzerland, LONDON, NEW YORK, and BOSTON, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Roivant Sciences Ltd. (Nasdaq: ROIV), a next-generation biopharmaceutical company dedicated to improving the delivery of healthcare to patients, announced today the commencement of a proposed underwritten pu...

Investor call and webcast scheduled for Monday, November 14 at 8:00 a.m. EST Roivant will present at investor conferences in November BASEL, Switzerland and LONDON and NEW YORK and BOSTON, Oct. 18, 2022 (GLOBE NEWSWIRE) -- Roivant Sciences (Nasdaq: ROIV) today announced...

What’s Going On In The Stock Market Today This stock market game is a tough one to play this year if you’re not prepared. Whether you’re trading penny stocks or Apple ( NASDAQ:AAPL ), volatility is high, which means knowing how to pivot. In the stock mar...

Get ahead of the market by subscribing to Seeking Alpha's Stocks to Watch, a preview of key events scheduled for the coming week. The newsletter keeps you informed of the biggest stories set to make headlines, including upcoming IPOs, investor days, earnings reports and conference presentat...